Vaccine policies in France and Europe

Alain Fischer; Patrick Peretti-Watel; Jeremy Ward

doi:10.1016/j.coi.2024.102513

Vaccine policies in France and Europe

Curr Opin Immunol. 2024 Dec 14:92:102513. doi: 10.1016/j.coi.2024.102513. Online ahead of print.

Authors

Alain Fischer¹, Patrick Peretti-Watel², Jeremy Ward³

Affiliations

¹ Pediatric Immuno-Hematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), F-75015 Paris, France; Université de Paris, Imagine Institute, F-75015 Paris, France; Paris Descartes University, Sorbonne Paris Cité, Imagine Institute, INSERM UMR 1163, F-75015 Paris, France; Collège de France, F-75231 Paris, France. Electronic address: [email protected].
² Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France; ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France.
³ CERMES3 (INSERM, CNRS, EHESS, Université de Paris), Villejuif, France.

PMID: 39675153
DOI: 10.1016/j.coi.2024.102513

Abstract

This review outlines the outcome of the COVID-19 vaccination campaign in France and assesses the respective roles of information and coercion in its overall success. These data are then put into perspective of the evolution of vaccination acceptance in France.

Publication types

Review